drugset / Trial / NCT06629389
Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Parkinson disease (PD) is a chronic, progressive neurodegenerative disorder characterized by clinical motor and non-motor symptoms. Knowing the potential benefits has led to the use of cannabis as an alternative therapy.
Timeline
- Start
- 2024-11-28
- Primary completion
- 2025-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cannabidiol | Other / unclassified | 100 mg/ml | — |
| Comparator | Cannabidiol | Other / unclassified | 300 mg/ml | — |
| Comparator | Cannabidiol | Other / unclassified | 400 mg/ml | — |